Diabetes Mellitus, Type I Clinical Trial
Official title:
The Effect of Exercise on the Development of Hypoglycemia in Children With Type 1 Diabetes; A Study Being Conducted by the Diabetes Research in Children Network
Verified date | September 2016 |
Source | Jaeb Center for Health Research |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Federal Government |
Study type | Observational |
The main purpose of this study is to find out how often low blood sugar (hypoglycemia)
happens during the night after exercise in the late afternoon. The study also will see if
there are any factors that can predict if low blood sugar is going to develop. Blood samples
will also be drawn to measure two hormones—glucagon and epinephrine (adrenaline)—to see how
they are affected by exercise. Glucagon helps to raise the blood sugar when it is low.
Epinephrine causes symptoms that make the person aware that the blood sugar is low. From the
blood sample, other substances in the blood may also be measured to see how they are
affected by exercise.
A second purpose of the study is to find out whether exercise affects the accuracy of a
continuous glucose sensor (CGMS made by Medtronic Minimed).
The study will also look at the accuracy of different home glucose meters.
Status | Completed |
Enrollment | 50 |
Est. completion date | November 2004 |
Est. primary completion date | |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 10 Years to 17 Years |
Eligibility |
Inclusion Criteria: - Clinical diagnosis of type 1 diabetes for at least 18 months - HbA1c <10.0% as measured by the DCA2000. - Age 10.0 to <18.0 years - Weight >36.0 kg - BMI (body mass index) >5th and <95th percentiles for age/gender - Stable insulin regimen for at least 1 month and not anticipating a change prior to the subject's completion of the study - Insulin regimen involves either use of an insulin pump or Lantus (with short-acting insulin) - NPH or Lente, if part of the insulin regimen, is given only in the morning before breakfast - Normal hematocrit (within normal limits of local laboratory) - Normal thyroid function (measured within the previous year) - Parent/guardian and subject understand the study protocol and agree to comply with it - Informed Consent Form signed by the parent/guardian and Child Assent Form signed Exclusion Criteria: - Insulin regimen includes Ultralente/Lente or NPH at times other than the morning before breakfast - A recent injury to body or limb, Addison's disease, muscular disorder, use of any medication or other significant medical disorder if that injury, medication or disease in the judgment of the investigator will affect the completion of the exercise protocol - Asthma which has been medically treated within the last year - Current use of glucocorticoid medication (by any route of administration) - Current use of a beta blocker medication - Use of pseudoephedrine 48 hours prior to CRC admission (if used in the 48 hours prior to the scheduled second admission, the admission will be deferred) - Severe hypoglycemia resulting in seizure or loss of consciousness in the 2 weeks prior to CRC admission (if a severe episode occurs within 2 weeks prior to the scheduled second admission, the admission will be deferred) - Active infection (if at the time of the planned second admission an infection is present, the admission will be deferred) - Anticipating a significant change in exercise regimen between admissions (i.e. starting or stopping an organized sport) |
Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
United States | Barbara Davis Center for Childhood Diabetes, University of Colorado | Denver | Colorado |
United States | Department of Pediatrics, University of Iowa Carver College of Medicine | Iowa City | Iowa |
United States | Nemours Children's Clinic | Jacksonville | Florida |
United States | Department of Pediatrics, Yale University School of Medicine | New Haven | Connecticut |
United States | Division of Pediatric Endocrinology and Diabetes, Stanford University | Stanford | California |
Lead Sponsor | Collaborator |
---|---|
Jaeb Center for Health Research | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
United States,
Diabetes Research In Children Network (Direcnet) Study Group, Buckingham BA, Kollman C, Beck R, Kalajian A, Fiallo-Scharer R, Tansey MJ, Fox LA, Wilson DM, Weinzimer SA, Ruedy KJ, Tamborlane WV. Evaluation of factors affecting CGMS calibration. Diabetes T — View Citation
Diabetes Research in Children Network (DirecNet) Study Group. Impaired overnight counterregulatory hormone responses to spontaneous hypoglycemia in children with type 1 diabetes. Pediatr Diabetes. 2007 Aug;8(4):199-205. — View Citation
Tansey MJ, Tsalikian E, Beck RW, Mauras N, Buckingham BA, Weinzimer SA, Janz KF, Kollman C, Xing D, Ruedy KJ, Steffes MW, Borland TM, Singh RJ, Tamborlane WV; Diabetes Research in Children Network (DirecNet) Study Group. The effects of aerobic exercise on — View Citation
Tsalikian E, Mauras N, Beck RW, Tamborlane WV, Janz KF, Chase HP, Wysocki T, Weinzimer SA, Buckingham BA, Kollman C, Xing D, Ruedy KJ; Diabetes Research In Children Network Direcnet Study Group. Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus. J Pediatr. 2005 Oct;147(4):528-34. — View Citation
Weinzimer SA, Beck RW, Chase HP, Fox LA, Buckingham BA, Tamborlane WV, Kollman C, Coffey J, Xing D, Ruedy KJ; Diabetes Research in Children Network Study Group. Accuracy of newer-generation home blood glucose meters in a Diabetes Research in Children Netw — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Hypoglycemia defined as <=70 mg/dL. | |||
Secondary | Changes in epinephrine and glucagon levels. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00351234 -
Carnitine Levels and Carnitine Supplementation in Type I Diabetes
|
N/A | |
Recruiting |
NCT00875290 -
The Effectiveness of Continuous Glucose Monitoring in Diabetes Treatment for Infants and Young Children
|
Phase 3 | |
Completed |
NCT00888628 -
Study of Islet Transplantation in Type 1 Diabetic Kidney Transplant Recipients
|
Phase 1/Phase 2 | |
Completed |
NCT00147342 -
The Effect of Insulin During Exercise on the Development of Low Blood Sugar in Individuals With Type I Diabetes
|
N/A | |
Completed |
NCT00493935 -
Effect of the Fat Content of the Bedtime Snack on Overnight Hypoglycemia
|
N/A | |
Completed |
NCT00118976 -
Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney Disease
|
N/A | |
Active, not recruiting |
NCT02081326 -
Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes
|
Phase 2 | |
Withdrawn |
NCT00790439 -
Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation After Kidney Transplant
|
Phase 2 | |
Completed |
NCT00789308 -
Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation
|
Phase 2 | |
Completed |
NCT02970357 -
Evaluation of the Impact of a Therapeutic Education Program for Children With Type 1 Diabetes
|
N/A | |
Completed |
NCT02521675 -
Validation of Algorithms for Basal Insulin Rate Reductions in Type 1 Diabetic Patients Practising Physical Activity in Real Life Conditions
|
N/A | |
Completed |
NCT01781975 -
Imatinib Treatment in Recent Onset Type 1 Diabetes Mellitus
|
Phase 2 | |
Completed |
NCT00368394 -
Dose-Exposure-Response in Type 1 Diabetes Mellitus
|
Phase 1 | |
Terminated |
NCT04591925 -
SteadiSet™ Pilot Study (SteP Study)
|
N/A | |
Not yet recruiting |
NCT06147583 -
Assessing Detection Algorithms for Insulin Pump Malfunctions in Type 1 Diabetes
|
N/A | |
Active, not recruiting |
NCT00306098 -
Islet Cell Transplantation Alone in Patients With Type 1 Diabetes Mellitus: Steroid-Free Immunosuppression
|
Phase 2 | |
Recruiting |
NCT05708820 -
Online Education Programme for People With Type 1 Diabetes and Suboptimal Metabolic Control
|
N/A | |
Completed |
NCT02556554 -
Pilot Prospective CGM Quality Improvement (QI) Project in Pregnancy
|
N/A | |
Completed |
NCT00652288 -
Evaluation of Pharmacokinetics and Pharmacodynamic Properties of Rapid-Acting Insulin Analogs
|
Phase 1 |